Literature DB >> 6113593

[3H]Bradykinin receptor binding in mammalian tissue membranes.

R B Innis, D C Manning, J M Stewart, S H Snyder.   

Abstract

[3H]Bradykinin binds to membranes from a variety of mammalian tissues in a saturable fashion with a dissociation constant of about 5 nM. Highest levels of binding are detected in guinea pig ileum, colon, and duodenum and in the oestrus rat uterus. The relative potencies of bradykinin derivatives in competing for these binding sites in guinea pig ileum membranes correlate with their contractile potencies in the ileum better than with contractile effects in the uterus. Thus, receptor recognition sites may differ in ileum and uterus. Monovalent and divalent cations at physiological concentrations reduce [3H]bradykinin binding. Of the monovalent cations, medium lowers binding 50% at about 80 mM. Among the divalent cations, calcium lowers binding about 50% at 5 mM, suggesting a link to the calcium conductance channel.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6113593      PMCID: PMC319403          DOI: 10.1073/pnas.78.4.2630

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  Release of pharmacologically active substances from the rat skin in vivo following thermal injury.

Authors:  M ROCHA E SILVA; S R ROSENTHAL
Journal:  J Pharmacol Exp Ther       Date:  1961-04       Impact factor: 4.030

2.  alpha-Noradrenergic receptors in the brain: differential effects of sodium on binding of [3H]agonists and [3H]antagonists.

Authors:  D A Greenberg; D C U'Prichard; P Sheehan; S H Snyder
Journal:  Brain Res       Date:  1978-01-27       Impact factor: 3.252

3.  Bradykinin-like immunoreactive neuronal systems localized histochemically in rat brain.

Authors:  F M Corrêa; R B Innis; G R Uhl; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

4.  Action of peptides and other algesic agents on paravascular pain receptors of the isolated perfused rabbit ear.

Authors:  H Juan; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

5.  Antinociceptive action of intraventricular bradykinin.

Authors:  S A Ribeiro; A P Corrado; F G Graeff
Journal:  Neuropharmacology       Date:  1971-11       Impact factor: 5.250

6.  Bradykinin receptor-like binding studied with iodinated analogues.

Authors:  C E Odya; T L Goodfriend; C Peña
Journal:  Biochem Pharmacol       Date:  1980-02       Impact factor: 5.858

7.  Interactions of divalent cations and guanine nucleotides at alpha 2-noradrenergic receptor binding sites in bovine brain mechanisms.

Authors:  D C U'Prichard; S H Snyder
Journal:  J Neurochem       Date:  1980-02       Impact factor: 5.372

8.  Plasma bradykinin levels and urinary kallikrein excretion in normal renin essential hypertension.

Authors:  J H Mersey; G H Williams; R Emanuel; R G Dluhy; P Y Wong; T J Moore
Journal:  J Clin Endocrinol Metab       Date:  1979-04       Impact factor: 5.958

9.  Histamine H1-receptor binding sites in guinea pig brain membranes: regulation of agonist interactions by guanine nucleotides and cations.

Authors:  R S Chang; S H Synder
Journal:  J Neurochem       Date:  1980-04       Impact factor: 5.372

10.  The effects of intra-arterial bradykinin, histamine, acetylcholine and prostaglandin E1 on nociceptive and non-nociceptive dorsal horn neurones of the cat.

Authors:  G Belcher
Journal:  Eur J Pharmacol       Date:  1979-07-01       Impact factor: 4.432

View more
  16 in total

Review 1.  Kinin receptors.

Authors:  F Marceau; D R Bachvarov
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

2.  Effect of a crude extract of Mandevilla velutina on contractions induced by bradykinin and [des-Arg9]-bradykinin in isolated vessels of the rabbit.

Authors:  J B Calixto; R A Yunes
Journal:  Br J Pharmacol       Date:  1986-08       Impact factor: 8.739

3.  Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions.

Authors:  L R Steranka; D C Manning; C J DeHaas; J W Ferkany; S A Borosky; J R Connor; R J Vavrek; J M Stewart; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

4.  [Effect of bradykinin on systemic and pulmonary hemodynamics in the human].

Authors:  G Bönner; U Schunk; S Preis; G Wambach; T Toussaint
Journal:  Klin Wochenschr       Date:  1989-11-03

5.  Expression cloning of a rat B2 bradykinin receptor.

Authors:  A E McEachern; E R Shelton; S Bhakta; R Obernolte; C Bach; P Zuppan; J Fujisaki; R W Aldrich; K Jarnagin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

6.  Identification of selective, high affinity [125I]-angiotensin and [125I]-bradykinin binding sites in rat intestinal epithelia.

Authors:  H M Cox; K A Munday; J A Poat
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

7.  The neuropeptide bradykinin stimulates phosphoinositide turnover in HSDM1C1 cells: B2-antagonist-sensitive responses and receptor binding studies.

Authors:  N A Sharif; R L Whiting
Journal:  Neurochem Res       Date:  1993-12       Impact factor: 3.996

8.  Blockade of non-opioid excitatory effects of spinal dynorphin A at bradykinin receptors.

Authors:  Yeon Sun Lee; Sara M Hall; Cyf Ramos-Colon; Michael Remesic; David Rankin; Todd W Vanderah; Frank Porreca; Josephine Lai; Victor J Hruby
Journal:  Receptors Clin Investig       Date:  2015

9.  Inositol phosphate metabolism in bradykinin-stimulated human A431 carcinoma cells. Relationship to calcium signalling.

Authors:  B C Tilly; P A van Paridon; I Verlaan; K W Wirtz; S W de Laat; W H Moolenaar
Journal:  Biochem J       Date:  1987-05-15       Impact factor: 3.857

10.  Receptors for bradykinin in intact cultured human fibroblasts. Identification and characterization by direct binding study.

Authors:  A A Roscher; V C Manganiello; C L Jelsema; J Moss
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.